Analyst Reco. Innate Pharma

Equities

IPH

FR0010331421

Market Closed - Euronext Paris Other stock markets 11:35:00 2024-05-15 am EDT			After market 03:59:56 pm
2.35 ^EUR	+1.08%		2.353	+0.13%

Apr. 15	Sanofi: progress in hematology trial	CF
Apr. 15	Innate Pharma: progress in hematology trial	CF

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ANALYST RECOMMENDATIONS : BHP, Lear, Naked Wines, Teradata, Visteon...	21-09-20
Innate Pharma S A : Shares Jump After SVB Leerink Upgrades Rating to Outperform	21-09-03	MT
INNATE PHARMA S A : SVB Leerink Upgrades Innate Pharma to Outperform from Market Perform	21-09-03	MT
INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From Outperform, Adjusts Price Target to $5 From $7	20-12-15	MT
INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50 From $13, Keeps at Buy	20-12-14	MT
INNATE PHARMA S A : Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target	20-11-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW